ACOEM provides tools.

As smoking may be the primary risk element for COPD, workplace smoking cessation programs are the most effective way for employers to greatly help their employees improve their lives and at the same time lower healthcare costs and absenteeism, said Barry Eisenberg, ACOEM executive director. Related StoriesSMU and University of Maryland researchers awarded NIH grant to fight pediatric asthmaResearchers compare performance of mixture therapy for black patients with asthmaASH study displays excessive smoking plays a part in ongoing poverty in West Midlands In depth worksite wellness initiatives with a robust smoking cessation system might help prevent or manage the chance of COPD by leveraging the power of prevention – the just sustainable solution to our society's health crisis, stated Ron Loeppke, MD, MPH, ACOEM President-elect.Dr. Eleanor Walker, lead writer of the analysis and division director of breasts services in the Division of Radiation Oncology at Henry Ford, confirmed this to be true when explaining the facts of the study. Two groups, one getting acupuncture because of their symptoms and the additional receiving Venlafaxine drug therapy, were observed over a 12 week period. Initially, all of the women experienced a 50 % decrease in hot flash and night sweat symptoms. By the end of the treatment period, nevertheless, the group that received Venlafaxine experienced an immediate increase in symptoms while the acupuncture group didn’t. The purpose of the analysis was to spotlight alternative remedies to Venlafaxine that could better alleviate the detrimental unwanted effects of breast cancer treatment and eventually encourage women to continue participating in it.